• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bio-Rad Laboratories (NY: BIO )

363.56 +5.38 (+1.50%)
Streaming Delayed Price Updated: 11:10 AM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Bio-Rad Laboratories

< Previous 1 2 3 Next >
Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference
October 31, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Reports Third-Quarter 2024 Financial Results
October 30, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024
October 14, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire
S&P 500 Shake-Up: New Entrants Driving Market Momentum
September 24, 2024
The quarterly rebalancing of the S&P 500 reflects market capitalization and performance shifts, highlighting growth and challenges in multiple sectors. 
Via MarketBeat
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
Bio-Rad Laboratories Inc. (NYSE: BIO) is a Leading Gainer in Wednesday Morning Trading
September 13, 2023
Via Investor Brand Network
Bio-Rad’s Management to Participate in Fireside Chat During Wells Fargo’s 2024 Healthcare Conference
August 22, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer
August 20, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Reports Second-Quarter 2024 Financial Results
August 01, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024
July 17, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire
OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Via AB Newswire
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Chronic conditions such as organ transplant rejection and cancer represent significant challenges in modern healthcare, demanding precise diagnostic tools for effective management and treatment. For... 
Via TheNewswire.com
Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group
May 30, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference
May 23, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Reports First-Quarter 2024 Financial Results
May 07, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference
May 01, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Announces Life Science Group Management Changes
April 26, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
April 18, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad’s Chief Operating Officer Andrew Last to Retire
April 10, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
March 20, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day
February 22, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
February 15, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024
January 24, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference
January 02, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Reports Third-Quarter 2023 Financial Results
October 26, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report Third Quarter 2023 Financial Results on Thursday, October 26, 2023
October 05, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference
August 28, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Reports Second-Quarter 2023 Financial Results
August 03, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement
July 26, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Announces New Share Repurchase Program
July 20, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023
July 10, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap